$202 Million is the total value of Sio Capital Management, LLC's 44 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 82.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CNC | New | CENTENE CORP DEL | $27,359,437 | – | 432,834 | +100.0% | 13.53% | – |
| CI | Buy | CIGNA GROUP | $22,275,828 | +27.8% | 87,175 | +65.7% | 11.01% | +70.8% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $20,575,471 | +1.7% | 967,347 | +41.5% | 10.17% | +36.0% |
| ABC | Buy | AMERISOURCEBERGEN CORP | $20,520,338 | +46.7% | 128,164 | +51.9% | 10.14% | +96.2% |
| UTHR | Buy | UNITED THERAPEUTICS CORP | $16,797,672 | +9.9% | 75,003 | +36.5% | 8.30% | +46.9% |
| New | GE HEALTHCARE TECHNOLOGIES INC | $16,150,641 | – | 196,887 | +100.0% | 7.98% | – | |
| OGN | Sell | ORGANON & CO | $11,090,927 | -32.4% | 471,553 | -19.8% | 5.48% | -9.7% |
| MDT | Sell | MEDTRONIC PLC | $6,773,047 | -31.9% | 84,012 | -34.4% | 3.35% | -9.0% |
| AVTR | Buy | AVANTOR INC | $5,985,495 | +13.5% | 283,136 | +13.3% | 2.96% | +51.7% |
| ADCT | New | ADC THERAPEUTICS SA | $4,213,232 | – | 2,160,632 | +100.0% | 2.08% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $4,162,500 | – | 250,000 | +100.0% | 2.06% | – |
| AXNX | New | AXONICS INC | $3,865,085 | – | 70,841 | +100.0% | 1.91% | – |
| GMED | New | GLOBUS MEDICAL INCcl a | $3,823,200 | – | 67,500 | +100.0% | 1.89% | – |
| RLAY | New | RELAY THERAPEUTICS INC | $3,788,314 | – | 230,013 | +100.0% | 1.87% | – |
| MACK | Buy | MERRIMACK PHARMACEUTICALS INC | $3,353,240 | +17.0% | 272,843 | +9.1% | 1.66% | +56.4% |
| RVMD | New | REVOLUTION MEDICINES INC | $2,728,229 | – | 125,957 | +100.0% | 1.35% | – |
| EUCRU | EUCRATES BIOMEDICAL ACQUISITION CORP.unit 10/23/2027 | $2,578,749 | +3.9% | 248,674 | 0.0% | 1.28% | +38.9% | |
| RPTX | New | REPARE THERAPEUTICS INC | $2,248,814 | – | 228,538 | +100.0% | 1.11% | – |
| CTIC | Buy | CTI BIOPHARMA CORP | $2,210,204 | +11.4% | 526,239 | +59.5% | 1.09% | +49.1% |
| SVRA | Buy | SAVARA INC | $1,849,491 | +37.7% | 948,457 | +9.5% | 0.91% | +83.9% |
| PHVS | Sell | PHARVARIS NV | $1,839,641 | -42.6% | 228,385 | -19.9% | 0.91% | -23.4% |
| HSKA | Sell | HESKA CORP | $1,703,469 | -67.5% | 17,450 | -79.3% | 0.84% | -56.6% |
| ELEV | Buy | ELEVATION ONCOLOGY INC | $1,665,561 | +387.4% | 876,611 | +143.7% | 0.82% | +553.2% |
| INGN | Sell | INOGEN INC | $1,516,757 | -73.2% | 121,535 | -57.6% | 0.75% | -64.1% |
| Buy | NYXOAH SA | $1,410,896 | +1655.1% | 188,875 | +1072.4% | 0.70% | +2223.3% | |
| CNTA | New | CENTESSA PHARMACEUTICALS PLCsponsored ads | $1,339,296 | – | 347,869 | +100.0% | 0.66% | – |
| New | APREA THERAPEUTICS INC | $1,243,200 | – | 280,000 | +100.0% | 0.62% | – | |
| New | CORBUS PHARMACEUTICALS HOLDINGS | $1,090,500 | – | 150,000 | +100.0% | 0.54% | – | |
| MODULAR MEDICAL INC | $999,560 | -27.5% | 689,352 | 0.0% | 0.49% | -3.1% | ||
| MBRX | Sell | MOLECULIN BIOTECH INC | $970,518 | -11.7% | 1,010,956 | -2.5% | 0.48% | +18.2% |
| IDYA | IDEAYA BIOSCIENCES INC | $961,100 | -24.4% | 70,000 | 0.0% | 0.48% | +1.1% | |
| FUSN | Sell | FUSION PHARMACEUTICALS INC | $927,556 | +13.1% | 246,036 | -5.5% | 0.46% | +51.5% |
| AGLE | AEGLEA BIO THERAPEUTICS INC | $871,438 | -35.5% | 3,004,959 | 0.0% | 0.43% | -13.8% | |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $840,582 | -16.6% | 123,797 | -9.2% | 0.42% | +11.5% |
| New | ASLAN PHARMACEUTICALS LTDspon ads new | $731,952 | – | 254,150 | +100.0% | 0.36% | – | |
| New | NEOVASC INC | $656,954 | – | 22,537 | +100.0% | 0.32% | – | |
| New | SIENTRA INC | $392,695 | – | 254,997 | +100.0% | 0.19% | – | |
| MRUS | Sell | MERUS NV | $286,378 | -79.0% | 15,564 | -82.3% | 0.14% | -71.8% |
| NXTC | NEXTCURE INC | $192,400 | +5.0% | 130,000 | 0.0% | 0.10% | +39.7% | |
| VINC | VINCERX PHARMA INC | $106,131 | +2.0% | 102,049 | 0.0% | 0.05% | +36.8% | |
| CMAX | Sell | CAREMAX INC | $82,078 | -31.0% | 30,741 | -29.4% | 0.04% | -6.8% |
| New | ROCKET PHARMACEUTICALS INC*w exp 09/02/2026 | $65,360 | – | 400,000 | +100.0% | 0.03% | – | |
| New | HUMACYTE INC*w exp 08/27/2026 | $29,936 | – | 49,998 | +100.0% | 0.02% | – | |
| CMAXW | New | CAREMAX INC*w exp 06/08/2026 | $5,668 | – | 12,808 | +100.0% | 0.00% | – |
| NLTX | Exit | NEOLEUKIN THERAPEUTICS INC | $0 | – | -38,312 | -100.0% | -0.01% | – |
| Exit | HUMACYTE INC*w exp 08/27/202 | $0 | – | -49,998 | -100.0% | -0.01% | – | |
| ASLN | Exit | ASLAN PHARMACEUTICALS LTDads | $0 | – | -1,270,758 | -100.0% | -0.17% | – |
| SIEN | Exit | SIENTRA INC | $0 | – | -2,550,000 | -100.0% | -0.19% | – |
| CNTB | Exit | CONNECT BIOPHARMA HOLDINGS LTDads | $0 | – | -597,678 | -100.0% | -0.19% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INCput | $0 | – | -235,600 | -100.0% | -0.30% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -235,500 | -100.0% | -0.30% | – |
| Exit | TYRA BIOSCIENCES INC | $0 | – | -152,159 | -100.0% | -0.43% | – | |
| XFOR | Exit | X4 PHARMACEUTICALS INC | $0 | – | -1,825,963 | -100.0% | -0.67% | – |
| ISEE | Exit | IVERIC BIO INCput | $0 | – | -86,400 | -100.0% | -0.68% | – |
| HSAQ | Exit | HEALTH SCIENCES ACQUISITIONS CORP 2 | $0 | – | -250,000 | -100.0% | -0.92% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCput | $0 | – | -67,000 | -100.0% | -0.94% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -555,610 | -100.0% | -1.29% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -340,000 | -100.0% | -1.29% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -434,635 | -100.0% | -1.75% | – |
| ICLR | Exit | ICON PLC | $0 | – | -33,983 | -100.0% | -2.44% | – |
| STAA | Exit | STAAR SURGICAL CO | $0 | – | -157,129 | -100.0% | -2.82% | – |
| DGX | Exit | QUEST DIAGNOSTICS INCput | $0 | – | -92,000 | -100.0% | -5.32% | – |
| MSAC | Exit | MEDICUS SCIENCES ACQUISITION | $0 | – | -2,323,000 | -100.0% | -8.65% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INCput | $0 | – | -574,200 | -100.0% | -23.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.